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     BSTRACT
Sepsis is a life-threatening condition in cattle, as in humans. Successful sepsis treatment requires 
a fast initiation of antimicrobial therapy with a broad-spectrum, bactericidal drug, administered 
intravenously. However, the new legislation limits the use of critically important fluoroquinolones 
and cephalosporins in food animal medicine, drugs which are considered highly effective for sepsis 
treatment and were previously frequently used for this indication. This article aims at providing an 
overview of the current knowledge of sepsis in cattle to aid practitioners in adapting their decision 
making process to treat sepsis. Sepsis incidence in cattle is likely seriously underestimated. This 
disease is almost unexplored in cattle, which makes it particularly difficult to design species specific 
guidelines. Sepsis diagnosis by blood culture reaches sufficient accuracy with the current labora-
tory technology. When adapting this procedure to a field environment, difficulties might arise, and 
the availability of adapted incubators in veterinary laboratories may be limited. However, these 
difficulties are likely to be overcome. Severe sepsis and septic shock are likely the only indications 
where the ‘urgency’ criterion of the new legislation would apply, but it is important to realize that 
alternative antimicrobial treatments with possibly similar efficacy are available.
SAMENVATTING
Sepsis is een levensbedreigende aandoening bij rundvee, net zoals bij de mens. Het snel toedienen 
van een breedspectrum-, bactericide antibioticum via intraveneuze weg is cruciaal voor een succesvolle 
behandeling van sepsis. De nieuwe wetgeving limiteert echter het gebruik van de kritisch belangrijke 
fluoroquinolonen en cefalosporinen bij voedselproducerende dieren. Deze antimicrobiële middelen 
worden als zeer effectief ervaren voor de behandeling van sepsis en werden vroeger dan ook veelvuldig 
ingezet voor deze indicatie. Het doel van dit artikel is een overzicht te geven van de huidige kennis 
over sepsis bij runderen om praktijkdierenartsen te sturen in hun beslissingsproces voor de behande-
ling van sepsis. De incidentie van sepsis bij rundvee wordt hoogstwaarschijnlijk ernstig onderschat. 
De ziekte werd vrijwel niet onderzocht bij runderen, wat het opstellen van speciesspecifieke richtlijnen 
sterk bemoeilijkt. De diagnose van sepsis door middel van bloedonderzoek is met de huidige laborato-
riumtechnologie voldoende accuraat. Mogelijke hinderpalen voor een meer veralgemeende toepassing 
zijn de minder hygiënische stalomgeving en de beperkte beschikbaarheid van aangepaste apparatuur in 
veterinaire labo’s, maar deze lijken niet onoverkomelijk. Ernstige sepsis en septische shock zijn mo-
gelijk de enige indicaties die in aanmerking komen voor het hoogdringendheidscriterium zoals in de 
wetgeving weergegeven, maar het is belangrijk in te zien dat er ook antimicrobiële behandelingen met 
niet kritisch belangrijke moleculen bestaan met een mogelijk gelijkaardige effectiviteit. 
A
INTRODUCTION
Sepsis is a life-threatening condition affecting hu-
mans and all animal species (Fecteau et al., 1997a; 
Rhodes et al., 2017). Sepsis refers to a dysregulated 
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systemic inflammatory response to the presence of 
bacteria in the bloodstream (Rhodes et al., 2017). 
To successfully treat sepsis, an early treatment with 
antimicrobials active against the involved bacteria is 
crucial. In practice, the critically important fluoroqui-
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nolones and cephalosporins are popular molecules for 
this indication, because of their bactericidal effects, 
broad-spectrum activity and relatively low resistance 
levels. Antimicrobial (multi)resistance in bacteria 
associated with sepsis is a problem in cattle and in 
humans (Marchese et al., 2012; Pardon et al., 2017). 
Current intensive antimicrobial use in food producing 
animals is under pressure (Callens et al., 2012; Lava 
et al., 2016; Pardon et al., 2012) and therefore, a cove-
nant has been negotiated between the federal govern-
ment and the involved sectors agreeing on a reduction 
in total antimicrobial use of 50% and in the use of 
critically important antimicrobials of 75% by 2020 
(AMCRA, 2016). In addition, a new legislation (KB 
July 21st, 2017) limits the use of critically important 
cephalosporins (third and fourth generation) and fluo-
roquinolones (first to third generation). Before these 
molecules can be used in food animals, the legislation 
requires (1) a clinical examination by the veterinar-
ian, (2) a bacterial cause of the disease, (3) adequate 
sampling and bacteriological culture in an accredited 
laboratory, (4) identification of the bacterial strain 
which likely caused the infection and (5) comparison 
of the strains susceptibility with at least seven other 
not-critically important antimicrobials, belonging to at 
least five different antimicrobial classes. Further, the 
legislation allows the following exceptions in which 
critically important antimicrobials can be used with-
out previous laboratory confirmation: (1) if no labora-
tory result is reached or sampling is impossible (in 
this case, the veterinarian can use the molecules based 
on recent scientific data); (2) if laboratory results ful-
filling the first five requirements above are available 
for the same group of animals in the same farm (valid 
for six months in veal calves and one year for other 
cattle operations) and finally (3) for ‘urgency’ reasons 
to save the life of a single animal. In the last case, 
the veterinarian needs to treat the patient him/herself, 
after a clinical examination, obligatory sampling and 
culturing. As soon as an antimicrobial susceptibility 
test result is reached, re-assessment of antimicrobial 
therapy and de-escalation to a non-critically impor-
tant antimicrobial is obliged, whenever possible.  
In this article, an overview is provided of the cur-
rent knowledge of sepsis in cattle to support practitio-
ners in their decision making process to rationally use 
antimicrobials in sepsis suspected patients. During 
the literature search, the lack of information on sepsis 
in cattle became painfully clear, and the authors were 
partly obliged to extrapolate knowledge from human 
medicine in an attempt to supply sufficient guidance. 
DEFINITIONS
In general, sepsis (septicemia) is a term to describe a 
systemic illness associated with the presence of micro- 
organisms and/or their toxins in the bloodstream 
(Fecteau et al., 2009). Bacteremia often refers to the 
presence of bacteria in the bloodstream, whereas sep-
sis also holds the systemic inflammatory response to 
these microorganisms. In sepsis with gram-negative 
bacteria, lipopolysaccharide (= endotoxin) is respon-
sible for an important part of the more severe inflam-
matory response compared to most gram-positive 
sepsis cases. Endotoxemia includes the presence of 
endotoxins in the bloodstream, causing similar symp-
toms as when accompanied by the bacteria itself. In 
veterinary medicine, most papers limit the diagnosis 
of sepsis to detection of bacteria in blood by culture 
(Hollis et al., 2008), either with additional clinical 
signs required (Fecteau et al., 1997a) or even without 
any confirmation of bacterial infection at all (Trefz et 
al., 2016). In contrast, in human medicine, different 
definitions are used to cover the whole spectrum of 
systemic inflammation and sepsis. In 1992, defini-
tions for systemic inflammatory response syndrome 
(SIRS), sepsis, severe sepsis, septic shock and mul-
tiple organ dysfunction syndrome (MODS) have been 
established (Bone et al., 1992). SIRS refers to any sys-
temic reaction, which occurs when the body fails to 
recognize or control a non-specific insult of either in-
fectious or non-infectious origin. SIRS is non-specific 
and can be caused by ischemia, inflammation, trauma, 
infection or any combination of these. SIRS is clini-
cally defined in humans as having two of the follow-
ing four clinical signs: (1) fever >38°C or < 36°C; (2) 
heart rate > 90 beats pro minute; (3) respiratory rate 
> 20 breaths pro minute or arterial partial pressure of 
carbon dioxide (PaCO2)< 32 mmHg and (4) abnormal 
white blood cell count (> 12 000 cells/µL or < 4000 
cells/µL or > 10% band cells) (Bone et al., 1992). 
Sepsis is the systemic response to infection and is cur-
rently defined as the presence of SIRS in addition to 
a documented bloodstream infection. Severe sepsis is 
characterized by sepsis with organ dysfunction (kid-
ney, liver, lung, heart, etc.) and is often accompanied 
by hypotension and hypoperfusion. Patients meet the 
criteria for septic shock if perfusion abnormalities and 
hypotension (systolic pressure <90 mmHg) persist de-
spite adequate fluid resuscitation (vasopressors need-
ed and lactate increased), and no signs of other types 
of shock. Septic shock is a combination of the three 
types of shock, namely cardiogenic, hypovolemic and 
distributive shock. Finally, MODS is a syndrome, in 
which multiple organs dysfunction.
The SIRS approach has been criticized a lot in the 
last decade, especially because often, persons with a 
simple respiratory infection already fulfill two criteria. 
In 2016, new definitions have been proposed in hu-
man medicine, which define sepsis as life-threatening 
organ failure caused by a dysregulated host response 
to infection (Singer, 2016). The sequential organ fail-
ure assessment score (SOFA) is the central concept, 
which evaluates breathing, circulation, liver and kid-
ney function, coagulation and the neurological condi-
tion. In first line practice, a quick SOFA score is rec-
ommended to identify those patients requiring urgent 
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treatment and referral to hospital. The quick SOFA 
score only evaluates three criteria: low blood pressure 
(systolic blood pressure ≤ 100 mmHg), high respira-
tory rate (≥ 22 breaths/min.) and an altered menta-
tion (Glasgow coma scale) in presence of a docu- 
mented or assumed infection. The qSOFA score has 
predicted mortality in hospital better than the SOFA 
or SIRS approach and has better identified persons re-
quiring urgent treatment and hospitalization (Freund 
et al., 2017). 
In summary, only a handful of studies on sepsis in 
cattle are available, with highly variable definitions 
(Fecteau et al., 1997a; Lofstedt et al., 1999; Trefz et 
al., 2016). It is clear that progress on sepsis manage-
ment and rational treatment in food animals can only 
be made if a universal terminology becomes avail-
able. To what extent the above mentioned human 
definitions can be extrapolated to animals needs to 
be determined. Practical difficulties certainly exist, as 
for example reliable blood pressure measurements in 
large animals in a field setting are not straightforward.
 
SEPSIS INCIDENCE, ETIOLOGY AND RISK 
FACTORS IN CATTLE
Only a handful of studies have determined the 
prevalence of sepsis in large animals, and mostly in a 
subset of critically ill animals being admitted to vet-
erinary (teaching) hospitals. In calves admitted with 
diarrhea and/or depression, 24-31% is bacteremic 
(Fecteau et al., 1997b). This is likely an underestima-
tion as these studies did not have the more sensitive, 
contemporary sampling and culturing techniques at 
their disposal (see section on diagnosis). 
Sepsis is regarded as a sporadic disease, but mas-
sive epidemics of sepsis can occur with virulent bac-
teria like Salmonella spp. (especially host adapted 
species like Salmonella Dublin), Histophilus somni, 
Mannhaemia haemolytica or Pasteurella multocida, 
especially in young animals (Catry et al., 2005; Mahu 
et al., 2015; McFadden et al., 2011). In the immuno-
compromised host, sepsis is more likely to occur. Risk 
populations are periparturient animals and calves, es-
pecially those with failure of passive transfer of ma-
ternal immunity (Lofstedt et al., 1999). Neonates lack 
a normal competitive intestinal flora, making coloni-
zation with virulent pathogens from the environment 
more easy. The source of the pathogenic bacteria in 
the neonate is most likely the contaminated environ-
ment and particularly, materials used to supply colos-
trum, which can be heavily contaminated. Outbreaks 
of sepsis with identical Escherichia coli clones have 
been described (Marchese et al., 2012), but to what 
extent blood culture results of a single case can be 
extrapolated to the whole of the group for a long pe-
riod of time is unknown. Calves might also be born 
septicemic after in utero infection or during parturi-
tion (prolonged parturition or vaginal passage in case 
of vaginal infections). In humans, group B Strepto-
cocci, which colonize the vagina, are a well-known 
cause of neonatal sepsis (Singer et al., 2016). To the 
authors’ knowledge, no such relationships between 
vaginal flora and sepsis have been substantiated in 
cattle. Also malnourishment, infection with immuno-
suppressive viruses (e.g. bovine viral diarrhea virus) 
and immune-mediated panmyelophtysis are risk fac-
tors (Pardon et al., 2010). In adult cattle, septicemic 
spread from ruminal bacteria after an acidosis episode 
or from a local site of infection (e.g. traumatic reticu-
loperitonitis, mastitis, arthritis, etc.) to other organs 
(causing liver abscesses, metastatic pneumonia or en-
docarditis) must not be underestimated. Especially in 
the North American feedlots, a liver abscesses preva-
lence of 60-63% has been reported, in cull cows even 
as high as 78% (Amachawadi and Nagaraja, 2016). 
Fear is that this prevalence will even increase, if the 
in-feed use of tylosin becomes restricted in the United 
States, as in Europe. 
The general message is that a multitude of bacteria 
can cause septicemia in the neonatal calf and in adult 
cattle. Gram-negative sepsis is far more common than 
gram-positive sepsis, in contrast to humans. In calves, 
the most commonly isolated bacterial family is the En-
terobacteriaceae, with E. coli (50-65% of all cases), 
Salmonella spp. and Klebsiella spp. being most com-
mon (Fecteau et al., 2009), followed by gram-positive 
cocci (Staphyloccocci and Streptococci) (12-14%), 
gram-positive rods (Trueperella pyogenes, Listeria 
spp., Bacillus spp.) (0-8%) and gram-negative non-
enteric rods (Pseudomonas aeruginosa, Mannheimia 
haemolytica, Acinetobacter spp., etc.) (0-8%). Anae-
robes (Bacteriodes spp. and Clostridium spp.) account 
only for a minority (0-6%) of sepsis cases. Despite 
that, also fungi and yeasts are well-known causes of 
sepsis in humans; there is no information available on 
their importance in large animals (Lamy et al., 2016). 
An interesting finding is that both in healthy peripar-
turient cows as in cows with acute metritis, a similar 
prevalence of Bacillus licheniformis bacteriemia has 
been found (56% vs. 53%, respectively) (Credille et 
al., 2014). More research is urgently needed to clarify 
this finding.
In humans, the main portals of entry are the in-
testinal tract, the oropharynx (tonsils), surgical sites, 
contaminated inhalators and catheter infections. In 
calves, the main portals of entry are the intestinal tract, 
the lungs and the umbilicus, whereas in adults, sepsis 
more frequently occurs in association with mastitis, 
metritis or ruminitis. Sepsis may also be iatrogenic, 
for example through injection. In a recent report, vac-
cine contamination with Streptococcus infantarius 
subsp. coli resulted in sepsis in 15% of the vaccina-
ted animals of which 57% died (Clarke et al., 2016). 
Surgical wounds and catheter infections are common 
causes of sepsis in humans, but have been hardly 
documented in calves. A recent report has shown how 
a single, multiresistent E. coli strain caused catheter-
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associated phlebitis in multiple calves and fatal sepsis 
in a single case (Pardon et al., 2017).
PREDICTION OF SEPSIS BASED ON CLINI-
CAL SIGNS
A crucial question is which symptoms need to be 
used to identify animals at risk for sepsis. This ques-
tion is particularly difficult in young calves, because 
severe dehydration and D-lactic acidosis are common 
and demonstrate similar clinical signs as sepsis (Lo-
renz, 2009). Also comorbidities, namely enteric in-
fection, D-lactic acidosis, pneumonia and sepsis, are 
frequent. 
Two studies have attempted to design a clinical 
model to predict septicemia in calves (Fecteau et al., 
1997a; Lofstedt et al., 1999). None have been found 
for adult cattle. The included calves in both studies 
were suffering from neonatal enteritis and/or depres-
sion arriving at a veterinary teaching hospital. Impor-
tant limitations of these studies are the sampling and 
culture methodology used to confirm sepsis. In one 
study, two blood samples of a limited sampling vol-
ume (7 ml) were used (Fecteau et al., 1997a). In the 
other study, different diagnoses, like positive blood 
culture, culture of the same bacteria from two body 
sides or culture from a joint were used (Lofstedt et 
al., 1999). Additionally, the obtained predictive mod-
els were not validated on a new dataset, limiting their 
external validity. Nevertheless, some information on 
which calves are at an increased sepsis risk can be 
derived from these studies and may aid practitioners 
in selecting suspected cases.   
The presence of a focal infection (omphalitis, ar-
thritis, hypopyon, soft tissue abscess or mucopuru-
lent nasal discharge) in the study by Fecteau et al. 
(1997a) and andomphalitis, joint effusion, hypopyon 
and neurological signs in the study by Lofstedt et 
al. (1999) remained a significant factor in the multi- 
variable model in both studies (Figure 1). The final 
model of one study consisted of focal infection, age 
(<5-7 days), posture (recumbent upon arrival 3.0 (1.3-
6.7 times higher odds than standing)) and a weak or 
absent suckling reflex (odds ratio (OR)= 1.1 (1.1-8.3)). 
This clinical model had a sensitivity (Se) and specific-
ity (Sp) of 39.4% and 90.6%, respectively (Lofstedt et 
al., 1999). With a sepsis prevalence of 30%, the nega-
tive predictive value was 78.8% for this model. In the 
study by Fecteau et al. (1997a), a sepsis score was 
designed, based on five clinical signs, namely fecal 
consistency, hydration, attitude, umbilicus and scleral 
vessels. The final model consisted of this sepsis score, 
age (> seven days of age in this case) and a focal site 
of infection. The disadvantage of a score is that it 
combines different variables, of which possibly only 
a single one explains the predictive effect. In the other 
study, hydration rate, attitude and scleral injections 
were univariably associated with sepsis, but did not 
remain significant in the final model (Figure 2). The 
final model of Fecteau’s study had a Se and Sp of 75% 
and 71%, respectively. An interesting observation is 
that in the study of Fecteau et al., no differences in 
rectal temperature, respiratory rate and heart rate were 
found between septicemic and normal calves, whereas 
Lofstedt et al. did find significant lower temperature 
and higher respiratory rates (heart rate not recorded) in 
septicemic calves, albeit very small differences. The 
above mentioned studies only dealt with the high risk 
group of diarrheic calves. For older animals, which 
frequently encounter pneumonia, no data is available 
to identify high risk animals. Although these predic-
tive models for bacteremia are a promising feature, 
apparently also in human medicine, few models have 
been prospectively validated or implemented in clini-
cal practice (Lamy et al., 2016). The authors mention 
additional workload for data entry as the main reason 
of reluctance to use these models.  
In summary, available evidence for using selected 
clinical signs or a sepsis score to predict septicemia in 
calves is very limited and hampered by several metho-
dological aspects. From the available work, some 
empirical directions can be derived. Young calves and 
animals with focal infections should be considered at 
Figure 1. Clinical signs of Listeria monocytogenes septice-
mia and meningitis in a two-week-old Belgian blue calf. 
Figure 2. Scleral injections are often regarded as highly 
suggestive of sepsis.
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an increased risk. In the authors’ opinion, blood culture 
sampling can be recommended in animals displaying 
depression, recumbency, tachycardia, tachypnea and 
an abnormal rectal temperature, especially when also 
a focal site of infection (e.g. neurological signs) or 
scleral injections are present. The combination of all 
these symptoms is a reflection of a more severe state 
of sepsis, rather than the earliest stage. Recommend-
ing the use of human SIRS and sepsis criteria to as-
sure early detection is in the authors’ opinion unwise 
given the current knowledge level of sepsis in calves. 
It holds the danger of overusing critically important 
antimicrobials in the field.  
ADDITIONAL BLOOD PARAMETERS AND 
BIOMARKERS
To confirm severe sepsis and MODS, additional 
blood parameters need to be tested. Renal failure, 
liver failure and respiratory failure are generally con-
firmed with increased renal values (creatinine and 
blood urea nitrogen), liver values and arterial blood 
PaO2 and PaCO2. The determination of possible organ 
failure is important for the prognosis, as the mortality 
risk in humans is 16-20% in sepsis or severe sepsis, 
compared to 46% in septic shock (Rangel-Frausto et 
al., 1995).
To improve the diagnostic accuracy of the models 
for sepsis, several blood parameters have been tested 
in a single calf study (Lofstedt et al., 1999). Failure of 
passive transfer, defined as an immunoglobulin G < 
10 g/L in a calf < 1 week, is a dominant risk factor for 
sepsis (OR= 2.7 (1.2-6.5)) (Lofstedt et al., 1999). Also 
a marked increase in serum creatinine, as would be 
seen in severe sepsis, and toxic changes in neutrophils 
are predictive for sepsis. The sensitivity and specific-
ity of this model were 40% and 95.4%, respectively. 
In the study, this laboratory model only improved 
specificity by 5% compared to the clinical model. The 
presence of band neutrophils, increased packed cell 
volume, decreased total protein and ionized calcium 
and increased PaCO2 were univariably associated 
with sepsis (Lofstedt et al., 1999). In contrast, total 
white blood cell and neutrophil count, fibrinogen, pH, 
base excess, bicarbonate, chloride, creatine kinase, 
gamma-glutamyl transferase, glucose, potassium and 
sodium could not be associated with septicemia.
Next to these parameters of a standard blood exa-
mination, predominantly in human medicine, a search 
for potent biomarkers to differentiate sepsis from 
other inflammatory processes is ongoing. Especially 
procalcitonin, the prohormone of calcitonin, has been 
put forward as a suitable sepsis marker in infants, 
with the optimal cut-off being >1.2 ng/mL (Se= 77%; 
Sp= 79%) (Delevaux et al., 2003; Park et al., 2014). 
Current advice in human medicine is to initiate broad 
spectrum antimicrobial therapy before culture results 
are returned in patients above this cut-off. Acute phase 
proteins are known to be highly species specific. In 
calves, PGE2, malondialdehyde (MDA), IL-8, TNF-α, 
IFN-y, neopterin and procalcitonin have been evalu-
ated in a single study (Ercan et al., 2016). The last 
four were significantly increased in E. coli septicemic 
calves. Ercan et al. (2016) also suggest procalcitonin 
to be the best marker as it increased four times, had a 
long half-time life and remained stable at room tem-
perature. In order to be practically useful for on-farm-
decision-making, the development of a cow-side test 
with this molecule will be necessary. 
Diagnosis by culture 
In humans, blood cultures are among the most com-
monly submitted microbiological samples, whereas 
they are only very occasionally used in food animals. 
Given the very limited information on large animals, 
extrapolation of human best practices is advisable. The 
method of choice is peripheral venipuncture, instead 
of blood collection through in place catheters, as it 
may harbor several bacteria. In humans, the contami-
nation rate of aseptically collected peripheral blood 
samples is 3.4-13% (Lamy et al., 2016). In veterinary 
clinics, similar aseptic conditions can be achieved, but 
likely, limiting contamination risk will be much more 
difficult when sampling in a stable environment. Af-
ter clipping, the use of alcoholic chlorhexidine is re-
commended by the Clinical and Laboratory Standards 
Institute (CLSI) guidelines for blood culture collec-
tion from infants > 2 months on (Lamy et al., 2016) 
(Figure 3). In most guidelines, sample collection is 
advised in the absence of antimicrobial therapy and at 
or around the time of fever spikes (Lamy et al., 2016). 
However, a recent study has shown that the likelihood 
of a positive blood culture is independent from the 
timing in respect of a temperature spike (Riedel et al., 
2008). In human guidelines, a minimum of two blood 
cultures, 30-60 minutes apart is recommended. The 
likelihood of detecting a blood stream infection de-
pends on the bacterial concentration in blood and the 
Figure 3. Sterile blood sampling procedure after clip-
ping and alcoholic chlorhexidine desinfection. 
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volume cultured, with the latter being most important 
(Lamy et al., 2016). Average bacterial concentrations 
in blood during sepsis (mean: 250 cfu/L blood; range: 
100-2000 cfu/L (Lamy et al., 2016)) are much lower 
than in local infections, making direct blood culture 
of low volumes very insensitive. The recovery rate in-
creases markedly with the increasing volume of blood 
cultured. Recovery rates for collected blood volumes 
of 20, 40 and 60 mL are 65-76%, 80-89% and 96-
98%, respectively (Lamy et al., 2016). Current recom-
mendations in humans include 3-4 blood culture sets 
with 20-30 mL collected per set. To counter the issue 
of low bacterial concentration in blood stream infec-
tions, also specific enrichment procedures (some hold 
resin or charcoal to neutralize antibiotic substances) 
with an automated detection system are common prac-
tice in hospital settings (e.g. Bactec (Beckton-Dickin-
son, USA) or BactAlert/Virtuo systems (bioMérieux, 
France)). The recommended volumes are 8-10 cc in 
bottles for adults and 1-5 cc in pediatric bottles. These 
machines automatically report when sufficient bacte-
rial growth is reached to allow standard culture tech-
niques and subsequent antimicrobial susceptibility 
testing. Point of attention is to also disinfect the top of 
each vial with a single alcohol swab and allow drying 
for 60 seconds, before injecting the collected blood. 
As mentioned, the volume cultured is the crucial fac-
tor. Attention should be payed to adequately fill the 
bottles, as inadequate filling is common and reduces 
sensitivity. These automated detection systems also 
result in a faster detection of the bacteria, which is 
crucial for a disease where every hour counts. It is im-
portant to realize that a complete blood culture holds 
three different media: an aerobic, an anaerobic and a 
medium for fungi and yeast. If an economic choice 
needs to be made, aerobic culture should be withheld. 
Clinicians can either opt for a multi-sampling 
strategy or a single-sampling strategy (Lamy et al., 
2016).The rationale behind the multi-sampling stra- 
tegy is that an increased volume is obtained, that con-
taminants may be distinguished from pathogens and 
that sensitivity is improved in cases of intermittent 
bacteremia. The disadvantages for application in vete-
rinary medicine are the need for repeated farm visits 
and more sampling material resulting in substantial 
extra costs. Moreover, repeated venipuncture in-
creases the contamination risk (more false positives) 
(Lamy et al., 2002). A large problem in humans is that 
frequently, only the first sample is submitted, possibly 
resulting in false conclusions. Apparently, the concept 
of intermittent bacteremia or fungemia as generally 
suspected has never been evidenced. In contrast, most 
clinical blood stream infections are associated with 
continuous bacteremia for 24 hours with very low 
concentrations of circulating microorganisms (Riedel 
et al., 2008). Hence, the interest in single-sampling 
strategies, yielding a higher volume (4-6 bottles) at 
one time has been regained. This methods assures 
enough volume sampled and a reduced risk of con-
tamination due to multiple punctures. It also reduces 
workload and the risk of occupational exposure to 
pathogens. Sensitivity of single sampling is equal to 
multi-sampling if the sampled blood volume is large 
enough (35-42 mL) (Lamy et al., 2002). Summarized, 
using these culture systems, the sensitivity and speci-
ficity of large volume single sampling is estimated 
at 95% and 97.5%, respectively (Lamy et al., 2002). 
Disadvantages are difficulties with collection of such 
volumes in certain patients through a single puncture, 
and the rather limited number of studies to confirm 
their equality to multi-sampling. A standard blood 
culture procedure takes 1-7 days, with only a minor-
ity of samples (2.7%) still turning positive between 5 
and 7 days (Marginson et al., 2014). Alternative tech-
nology to rapidly detect bacteria directly on blood 
samples is being developed. PCR has been used and 
may identify with high accuracy bacteria involved in 
blood stream infections within 4-8 hours (Ginn et al., 
2017). A disadvantage is the need for multiple primers 
to cover the most likely organisms. Another example 
is the use of the Sepsityper kit on the matrix assisted 
laser desorption/ionization time of flight (MALDI-
TOF) mass spectrometer, which enables species 
identification within a few hours (Morgenthaler and 
Kostrzewa, 2015). 
In summary, a single-sample strategy appears 
most achievable in the field and is likely to return an 
acceptable diagnostic accuracy, if a sufficient volume 
is cultured. Determination of its Se and Sp is urgently 
needed. Alternatively, documentation of an infected 
body site in an animal with signs of sepsis might be 
considered. For some sites (e.g. lung, udder, bladder), 
interpretation may be straightforward, whereas it is 
virtually impossible for intestinal or throat samples. 
Antimicrobial susceptibility testing
It is outside the scope of this paper to go into detail 
on the advantages and disadvantages of the different 
methods for antimicrobial susceptibility testing. It is 
however important to realize that there is no 100% 
agreement between the commonly used disk-diffu-
sion method and the micro-dilution gold standard pro-
cedure, as demonstrated for Pasteurellaceae (Catry et 
al., 2007). Very important mistakes resulting in not 
treating an animal or treating it with an inadequate 
antimicrobial when treatment is required, were for ex-
ample present in 3.7% and 7.4% of P. multocida and 
M. haemolytica isolates, respectively. Fast diagnos-
tics are crucial to guide rational sepsis treatment. With 
MBT-ASTRA, a MALDI TOF procedure, an antibio-
gram could be reached as fast as one to three hours 
post culture initiation, also for veterinary pathogens 
like Pasteurella multocida (Sparbier et al., 2016; Van 
Driessche et al., 2017). This technology completely 
meets the demand for fast diagnostics, which is also 
crucial in food animal medicine if prudent antimicro-
bial use needs to be combined with maximization of 
patient survival chances.
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Therapy
Sepsis therapy has three priorities: (1) immediate 
stabilization of the patient (airway, breathing, circula-
tion); (2) removal of bacteria from the blood stream as 
fast as possible and (3) treatment of the original focus 
of infection. The key factor for successful antimicro-
bial therapy for sepsis is to be early and appropriate. 
Appropriate antimicrobial therapy (= therapy with an 
antimicrobial to which the bacteria are susceptible) 
must be initiated as soon as possible, because delay 
is associated with increased mortality (for each hour 
+ 6% mortality risk) (Dellinger et al., 2013). Early 
signifies administration within <30-60 minutes after 
recognition of severe sepsis or septic shock. 
In the absence of culture and antimicrobial sus-
ceptibility test results, initial antimicrobial therapy is 
considered empiric. The primary criterion for empiric 
antimicrobial drug selection is spectrum. Because of 
the high mortality associated with septic shock, em-
piric therapy should cover both gram-positive and 
gram-negative bacteria (broad spectrum). Based on 
the probable anatomic site of infection (lungs, um-
bilicus, intestines, etc), an informed selection of 
an antimicrobial able to reach this site, needs to be 
made. Other criteria for antimicrobial selection are 
local antimicrobial resistance data on the most likely 
pathogens, earlier antimicrobial therapies and avail-
able susceptibility testing results from local infections 
(Liang and Kumar, 2015). To rapidly and effectively 
clear the blood stream infection, a bactericidal anti-
microbial is recommended (Liang and Kumar, 2015). 
Antimicrobials are often combined, not only to reach 
broad spectrum activity, but also to increase potency, 
reaching higher cidality by attacking the bacteria by 
different mechanism of action. Evidence of increased 
cidality is available for β-lactam/aminoglycoside 
and β-lactam/fluoroquinolone combinations, but no 
marked benefit for clinical outcomes could be evi-
denced in the available meta-analyses, except for the 
very critically ill (septic shock) (Liang and Kumar, 
2015). 
Next to the antimicrobial drug selected, optimiza-
tion of the dosing regimen plays a crucial role in cidal-
ity. Intravenous administration is generally preferred 
as it results in the fastest increase in blood concentra-
tion. In the critically ill patient, altered pharmacokine-
tics are present, with an increased distribution volume 
for β-lactams and aminoglycosides, possibly resulting 
in subtherapeutic concentrations (Liang and Kumar, 
2015). Therefore, current recommendation is that ini-
tial antimicrobial therapy in septic shock should begin 
with the maximum recommended dose. For time-de-
pendent antibiotics, the effective time above the mini-
mum inhibitory concentration (MIC) can be improved 
by either a more frequent dosing regimen or by con-
tinuous infusion therapy (after a high loading dose). 
To optimize concentration-dependent killing agents 
(aminoglycosides and fluoroquinolones), the area un-
der the curve (AUC) in 24h/MIC ratio and the peak 
antimicrobial concentration (Cmax)/MIC ratio need to 
be maximized; in brief, this signifies the use of the 
maximum non-toxic dose for a concentration-depen-
dent antibiotic (Liang and Kumar, 2015). In cattle, 
the renal toxicity of gentamicin is feared, especially 
in dehydrated patients. Determination of creatinine/
blood urea nitrogen and fluid therapy may counteract 
this issue. An overdose of fluoroquinolones can result 
in neurological signs (depression, incoordination, 
musclefasciculation, transient nystagmus, recumbency 
and possibly death) (Anonymous, 2007). An advan-
tage of using higher dosages of fluoroquinolones is 
that the mutant prevention concentration (MPC) is 
reached, limiting the development of antimicrobial re-
sistance in at least the targeted pathogen (principles of 
the single injection short acting antibiotic (SISAAB) 
concept) (Balaje et al., 2013).  
Equally important as the fast initiation of antimi-
crobial therapy is the timely recognition of therapy 
failure. When culture and susceptibility test results 
are available (2-4 days minimum, depending on the 
bacteria), antibiotic reassessment needs to be done. 
Inappropriate empirical antimicrobial therapy is de-
fined as the use of an antimicrobial demonstrated in-
sensitive for the cultured bacteria, and has been asso-
ciated with a fivefold increase in mortality in humans 
(Kumar, 2009). In contrast, effective antibiotic reas-
sessment has been associated with a better outcome in 
humans (Aillet et al., 2017). De-escalation is the gen-
eral principle, signifying that a shift to a more narrow-
spectrum antimicrobial is made. Research is ongoing, 
but de-escalation does not appear to adversely impact 
survival in humans (Leone et al., 2014). A treatment 
length of seven to ten days is recommended in hu-
mans, although the evidence for this advice is consid-
ered weak, and more and more, preference is given to 
the shortest treatment length possible (Rhodes et al., 
2017). To achieve this, daily assessment of the possi-
bilities to de-escalate or stop antimicrobial therapy is 
necessary. The whole of this approach should be part 
of an antimicrobial stewardship program at the level 
of the veterinary hospital, practice or farm.
Available formularies in the Netherlands and Bel-
gium suggest sulfonamides-trimethoprim as the pri-
mary choice for sepsis in cattle. Secondary choices are 
broad-spectrum β-lactams (amoxicillin, ampicillin), 
or the combination of penicillin with an aminoglyco-
side (neomycine or gentamicin) or dihydrostreptomy-
cin. Tertiary choices consist of the critically important 
fluoroquinolones and cephalosporins of the third and 
fourth generation (AMCRA, 2014; KNMVD, 2017). 
To the authors’ knowledge, no randomized clinical tri-
als on the effectiveness of any of these treatments to 
survive sepsis have been conducted in cattle. Based 
on the above information and guidelines from human 
medicine, in severe sepsis or septic shock cases, pref-
erence should be given to an intravenous and bacteri-
cidal drug in high dosage. Critically important fluo-
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roquinolones or cephalosporins comply with this re-
quirements, but this is also the case for sodium amoxi-
cillin/ampicillin (with or without clavulanic acid) or 
the combination sodium penicillin and gentamicin. It 
should be remarked that intravenous administration of 
(amino)-penicillins is off-label antimicrobial use and 
a cascade application in Belgium. 
The focus of this article is on antimicrobial thera-
py. Patient stabilization and ancillary anti-inflamma-
tory therapy will only be limited to what is achievable 
in the field and evidenced in cattle. In severe sepsis 
or septic shock, fluid therapy with isotonic saline is 
recommended at 30 mL/kg bodyweight in 5-20 min-
utes to sustain blood pressure (Dellinger et al., 2017). 
Glucose administration is controversial but common 
practice in pediatric medicine, and is likely needed in 
the hypoglycemic calf. As to the use of anti-inflam-
matory drugs, corticosteroids are controversial in 
human medicine. The advice of the ‘surviving sep-
sis campaign’ is against their use in sepsis or septic 
shock responding on fluid therapy. If fluid therapy and 
vasopressors fail to restore blood pressure, corticoste-
roid administration is suggested (Rhodes et al., 2017). 
Surprisingly and totally in contrast to animal models 
where non-steroidal inflammatory drugs (NSAIDs) 
(cyclooxygenase inhibitors) display beneficial effects 
for mortality, human studies have failed to demon-
strate clinical utility of NSAIDs in sepsis treatment 
(Aronoff, 2012). To the authors’ knowledge, for the 
use of NSAIDs for sepsis in cattle, no randomized 
clinical trials are available neither. Work on experi-
mental endotoxemia in calves has shown no effects 
of corticosteroids, whereas ketoprofen completely al-
leviated all symptoms (Plessers et al., 2012; Plessers 
et al., 2016).
PREVENTION
The optimal method to avoid antimicrobial use for 
sepsis is of course to prevent septicemia from happen-
ing. Sepsis in large animals is largely unexplored, and 
to the authors’ knowledge, no substantial epidemio-
logical studies on risk factors for septicemia are avail-
able. Avoiding failure of passive transfer by effective 
colostrum management is to date the most accessible 
preventive measure that can be taken (Lofstedt et al., 
1999). In addition, attention should be paid to the ad-
equate hygiene of colostrum delivery materials. In hu-
man medicine, the importance of adequate hygiene in 
catheter placement or injection procedures in sepsis 
prevention has been made clear. It is also important to 
realize that in certain high risk situations in humans, 
like group B streptococcal infections at parturition, 
preventive antimicrobial use is considered rational. 
To date, no evidence for such indications in food ani-
mal medicine is available, and preventive antimicro-
bial use should be discouraged at all times. 
CONCLUDING REMARKS
Sepsis is likely a seriously underestimated pro-
blem in cattle, previously masked by empirical, 
broad-spectrum antimicrobial therapy and limited 
diagnostic efforts. Dealing with sepsis already is a 
true challenge for the bovine practitioner, and has be-
come more complicated in face of the new legislation. 
Severe sepsis and septic shock are a typical indication 
(if not the only one) where the argument of ‘urgency’, 
as mentioned in the legislation, appears justified. Ade-
quate sampling to obtain a susceptibility test result is 
perfectly possible, either by blood culture or alterna-
tively by sampling the local focus of infection (e.g. 
lung or udder). However, training to improve sample 
quality might be necessary and easy access to the re-
quired laboratory technology might not be covered 
in the whole of the country. Study priorities in this 
area are the identification of clinical and biochemical 
predictors of the different grades of sepsis to provide 
a clear definition of what is considered ‘urgent’, and 
randomized clinical trials comparing different anti-
microbial regimens and evidencing the benefit and 
practical achievability of de-escalation procedures in 
bovine practice. In order to safeguard their efficacy 
for human and veterinary medicine, fluoroquinolone 
and cephalosporin use for animals should be highly 
exceptional. 
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